Azienda Ospedaliera Universitaria Meyer IRCCS

Florence 50139

8 studies enrolling now · 8 studies all time

What they study most

Angelman Syndrome, Crohn's Disease, Danon Disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Epileptic Encephalopathy, Inflammatory Bowel Diseases, Pediatric, Symptomatic Obstructive Hypertrophic Cardiomyopathy, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS) — Recruiting now
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) — Recruiting now
• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) — Recruiting now
• A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy — Recruiting now
• Danon Disease Natural History Study — Recruiting now
• A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). — Recruiting now
• A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes — Starting soon